The COVID-19 pandemic has continued to spread worldwide, with an increasing number of global infections and the continual emergence of new variants. Are the existing vaccines still effective against new variants? How protective are these vaccines? These questions need to be answered urgently. As a result, the demand for neutralizing antibody tests and recombinant proteins for new variants is increasing.
Download this whitepaper to discover the answers to questions such as:
- What are neutralizing antibodies?
- Why should we detect neutralizing antibodies?
- What methods of detection are available?